These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24625634)

  • 1. Yellow Fever outbreaks in unvaccinated populations, Brazil, 2008-2009.
    Romano AP; Costa ZG; Ramos DG; Andrade MA; Jayme Vde S; Almeida MA; Vettorello KC; Mascheretti M; Flannery B
    PLoS Negl Trop Dis; 2014 Mar; 8(3):e2740. PubMed ID: 24625634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse events following yellow fever immunization: Report and analysis of 67 neurological cases in Brazil.
    Martins Rde M; Pavão AL; de Oliveira PM; dos Santos PR; Carvalho SM; Mohrdieck R; Fernandes AR; Sato HK; de Figueiredo PM; von Doellinger Vdos R; Leal Mda L; Homma A; Maia Mde L
    Vaccine; 2014 Nov; 32(49):6676-82. PubMed ID: 24837504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: systematic review.
    Thomas RE; Lorenzetti DL; Spragins W; Jackson D; Williamson T
    Vaccine; 2011 Jun; 29(28):4544-55. PubMed ID: 21549787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance for yellow Fever virus in non-human primates in southern Brazil, 2001-2011: a tool for prioritizing human populations for vaccination.
    Almeida MA; Cardoso Jda C; Dos Santos E; da Fonseca DF; Cruz LL; Faraco FJ; Bercini MA; Vettorello KC; Porto MA; Mohrdieck R; Ranieri TM; Schermann MT; Sperb AF; Paz FZ; Nunes ZM; Romano AP; Costa ZG; Gomes SL; Flannery B
    PLoS Negl Trop Dis; 2014 Mar; 8(3):e2741. PubMed ID: 24625681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with severity of adverse events following yellow fever vaccination during the biggest outbreak of the disease recorded in Brazil, 2016-2017.
    Lucena ARFP; Souza LRO; Percio J; Carvalho SMD; Romano APM; Domingues CMAS
    Epidemiol Serv Saude; 2020; 29(1):e2018331. PubMed ID: 32215531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A public health risk assessment for yellow fever vaccination: a model exemplified by an outbreak in the state of São Paulo, Brazil.
    Ribeiro AF; Tengan C; Sato HK; Spinola R; Mascheretti M; França AC; Port-Carvalho M; Pereira M; Souza RP; Amaku M; Burattini MN; Coutinho FA; Lopez LF; Massad E
    Mem Inst Oswaldo Cruz; 2015 Apr; 110(2):230-4. PubMed ID: 25946247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Yellow fever: reemerging in the state of Sao Paulo, Brazil, 2009].
    Mascheretti M; Tengan CH; Sato HK; Suzuki A; de Souza RP; Maeda M; Brasil R; Pereira M; Tubaki RM; Wanderley DM; Fortaleza CM; Ribeiro AF;
    Rev Saude Publica; 2013 Oct; 47(5):881-9. PubMed ID: 24626492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Overdose of yellow fever vaccine in the Southern region of Brazil].
    Carneiro M; Lara Bda S; Schimidt B; Gais L
    Rev Soc Bras Med Trop; 2011; 44(2):252-3. PubMed ID: 21552746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yellow fever outbreaks in São Paulo State, Brazil, 2000-2010.
    Saad LD; Barata RB
    Epidemiol Serv Saude; 2016; 25(3):531-540. PubMed ID: 27869924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse events following yellow fever vaccination in immunocompromised persons.
    Lara AN; Miyaji KT; Ibrahim KY; Lopes MH; Sartori AMC
    Rev Inst Med Trop Sao Paulo; 2021; 63():e13. PubMed ID: 33656136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yellow fever vaccination: how much is enough?
    Massad E; Coutinho FA; Burattini MN; Lopez LF; Struchiner CJ
    Vaccine; 2005 Jun; 23(30):3908-14. PubMed ID: 15917112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal Yellow Fever in Travelers to Brazil, 2018.
    Hamer DH; Angelo K; Caumes E; van Genderen PJJ; Florescu SA; Popescu CP; Perret C; McBride A; Checkley A; Ryan J; Cetron M; Schlagenhauf P
    MMWR Morb Mortal Wkly Rep; 2018 Mar; 67(11):340-341. PubMed ID: 29565840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How many published cases of serious adverse events after yellow fever vaccination meet Brighton Collaboration diagnostic criteria?
    Thomas RE; Spragins W; Lorenzetti DL
    Vaccine; 2013 Dec; 31(52):6201-9. PubMed ID: 24436960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological characteristics of yellow fever in Brazil, 2000-2012.
    Cavalcante KR; Tauil PL
    Epidemiol Serv Saude; 2016; 25(1):11-20. PubMed ID: 27861674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active assessment of adverse events following yellow fever vaccination of persons aged 60 years and more.
    Miyaji KT; Luiz AM; Lara AN; do Socorro Souza Chaves T; Piorelli Rde O; Lopes MH; Sartori AM
    Hum Vaccin Immunother; 2013 Feb; 9(2):277-82. PubMed ID: 23291944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological adverse events temporally associated to mass vaccination against yellow fever in Juiz de Fora, Brazil, 1999-2005.
    Fernandes GC; Camacho LA; Sá Carvalho M; Batista M; de Almeida SM
    Vaccine; 2007 Apr; 25(16):3124-8. PubMed ID: 17316927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serious adverse events associated with yellow fever vaccine.
    de Menezes Martins R; Fernandes Leal Mda L; Homma A
    Hum Vaccin Immunother; 2015; 11(9):2183-7. PubMed ID: 26090855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of yellow fever vaccine in Indian travellers: A prospective observational study.
    Tiwari P; Ahlawat R; Gupta G
    Indian J Med Res; 2016 Nov; 144(5):778-780. PubMed ID: 28361832
    [No Abstract]   [Full Text] [Related]  

  • 19. Yellow Fever Vaccine-Associated Viscerotropic Disease among Siblings, São Paulo State, Brazil.
    Fernandes EG; Gomes Porto VB; de Oliveira PMN; Duarte-Neto AN; de Sousa Maia ML; Lignani LK; Nogueira JS; Teixeira GV; Iglezias SD; Blanco RM; Sato HK
    Emerg Infect Dis; 2023 Mar; 29(3):493-500. PubMed ID: 36823036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of the yellow Fever vaccine: a retrospective study.
    Nordin JD; Parker ED; Vazquez-Benitez G; Kharbanda EO; Naleway A; Marcy SM; Molitor B; Kuckler L; Baggs J
    J Travel Med; 2013; 20(6):368-73. PubMed ID: 24118538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.